Pasithea Therapeutics Corp. Insider Trading

KTTA

⊜ Compare

Last 12 months

Insiders bought 150K on the open market and sold nothing.

Net open-market

+150K

3 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

3 / 0

executives and directors

Last open-market buy

Nov 2025

Nov 28, 2025

Get an email when KTTA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 17	Coastlands Capital LP Large holder	Bought	100,000	$0.53	53K	2.7%	Form 4
Nov 28, 2025	Lawrence Steinman Director	Bought	133,333	$0.75	100K	201%	Form 4
Nov 28, 2025	Tiago Marques Chief Executive Officer	Bought	33,333	$0.75	25K	83%	Form 4
Nov 28, 2025	Simon Dumesnil Director	Bought	33,333	$0.75	25K	1333%	Form 4
May 12, 2025	Tiago Marques Chief Executive Officer	SoldNo plan	960	$0.83	$797	2.3%	Form 4

Jun 17
Coastlands Capital LP
Large holder · bought 100,000 at $0.53
53K
2.7% of stake
Nov 28, 2025
Lawrence Steinman
Director · bought 133,333 at $0.75
100K
201% of stake
Nov 28, 2025
Tiago Marques
Chief Executive Officer · bought 33,333 at $0.75
25K
83% of stake
Nov 28, 2025
Simon Dumesnil
Director · bought 33,333 at $0.75
25K
1333% of stake
May 12, 2025No plan
Tiago Marques
Chief Executive Officer · sold 960 at $0.83
$797
2.3% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch KTTA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with KTTA

CompareIntrinsic value

BIOEBio Essence Corp

$0.47+0.00%80

RNTXRein Therapeutics Inc.

$0.66-1.39%10

ANVSAnnovis Bio, Inc.

$1.21+11.01%10

EVFMEvofem Biosciences Inc.

$0.01+0.00%15

HCWBHCW Biologics Inc.

$1.08-6.09%15

CUECue Biopharma, Inc.

$19.84-4.89%40

BYSIBeyondSpring Inc.

$0.68+9.34%10

CAPRCapricor Therapeutics Inc.

$8.92+8.25%10

Held by ETFs

KTTA is in 1 US ETF. The largest of them, with KTTA's weight in each:

PSAdvisorShares Psychedelics ETFPSIL1.09%of the fund

Spot a number that looks wrong? Check it in KTTA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing KTTA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.